FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Widening its overseas markets with botulinum toxin approvals in China and Kuwait.

  • Approval of its botulinum toxin in Kuwait. Source
  • Approval of its botulinum toxin in China. Source

Roles often seen at this stageRegulatory affairs · Sales & marketing · Manufacturing & MSAT

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Huons BioPharma

The maker of the botulinum toxin Liztox (Hutox abroad), approved in 16 countries.

Completion reported

Its Chinese partner received approval for Hutox in China.

Completion reported

Received Hutox approval in Kuwait, its first entry into the Gulf region.

Official role guide

Huons BioPharma careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 휴온스바이오파마, A형 보툴리눔 톡신 中 허가 획득 ↗네이트 뉴스 · Published 2026-01-09 · Sources checked 2026-11-15 · Original unavailable
  2. 휴온스바이오파마, 보툴리눔 톡신 '휴톡스' 쿠웨이트 품목허가 획득 ↗머니투데이 · Published 2026-05-08 · Sources checked 2026-11-15 · Original unavailable